Zdrowie i gospodarka · 07/04/2014

FDA Requests Public Comment on Proposed Collection of Information for Adverse Experience Reporting and General Records

The Food and Drug Administration (FDA) is seeking public input on a proposed extension of its Adverse Experience Reporting System (AERS) for licensed biological products and general records related to the manufacture and distribution of these products, as required by the Paperwork Reduction Act of 1995.